Overview
Peng Lin practices in Guangzhou, China. Mr. Lin is rated as a Distinguished expert by MediFind in the treatment of Esophageal Cancer. His top areas of expertise are Esophageal Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thyroid Cancer, and Endoscopy.
His clinical research consists of co-authoring 106 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 58 articles and participated in 2 clinical trials in the study of Esophageal Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Esophageal CancerMr. Lin isDistinguished. Learn about Esophageal Cancer.
- Advanced
- Lung CancerMr. Lin isAdvanced. Learn about Lung Cancer.
- Experienced
- EndoscopyMr. Lin isExperienced. Learn about Endoscopy.
- Follicular Thyroid CancerMr. Lin isExperienced. Learn about Follicular Thyroid Cancer.
- Lung AdenocarcinomaMr. Lin isExperienced. Learn about Lung Adenocarcinoma.
- Mediastinal TumorMr. Lin isExperienced. Learn about Mediastinal Tumor.
- Non-Small Cell Lung Cancer (NSCLC)
- Papillary Thyroid CancerMr. Lin isExperienced. Learn about Papillary Thyroid Cancer.